Cancer and Portfolio Choice: Evidence from Norwegian Register Data
Abstract We examine the personal investment decisions of 60,000 households following a cancer diagnosis. To create a control group that minimizes the likelihood that the results are confounded by lifestyle factors, we rely on households diagnosed with the same diagnosis but a few years later. Our es...
Gespeichert in:
| Veröffentlicht in: | Review of Finance 2022-03, Vol.26 (2), p.407-442 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 442 |
|---|---|
| container_issue | 2 |
| container_start_page | 407 |
| container_title | Review of Finance |
| container_volume | 26 |
| creator | Døskeland, Trond Kvaerner, Jens Soerlie |
| description | Abstract
We examine the personal investment decisions of 60,000 households following a cancer diagnosis. To create a control group that minimizes the likelihood that the results are confounded by lifestyle factors, we rely on households diagnosed with the same diagnosis but a few years later. Our estimates show that a cancer diagnosis reduces households’ willingness to take risks with their financial wealth. We use the vast heterogeneity among cancers regarding its impact on life expectancy (LE) and income to analyze through which channels cancer impact risk-taking. We find that cancers that have a greater impact on LE and income cause a larger reduction in risk-taking. These two channels account for about 40–90% of the estimated effects of cancer on personal investment decisions. We do not find any association between having dealt with cancer many years ago and current portfolio choices. |
| doi_str_mv | 10.1093/rof/rfab022 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3134864593</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/rof/rfab022</oup_id><sourcerecordid>3134864593</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-3c6082617ef9d6c5288db8c53dd2c77894b0cca49a3a407c513cb924db3ce3c43</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouK6e_AMBwYvUTTJpm3jTun7AoiIK3kI6TbXLbrMmXcV_b7UL3jy9A_PMO_AQcsjZKWcaJsHXk1DbkgmxRUY8zSHJtHjZ_p1FAkznu2QvxjljAALSEbkobIsuUNtW9MGHrvaLxtPizTfozuj0o6lcv6d18Et658One21sSx_7iF1_dmk7u092aruI7mCTY_J8NX0qbpLZ_fVtcT5LUHLdJYAZUyLjuat1lWEqlKpKhSlUlcA8V1qWDNFKbcFKlmPKAUstZFUCOkAJY3I09K6Cf1-72Jm5X4e2f2mAg1SZTDX01MlAYfAxBlebVWiWNnwZzsyPJNNLMhtJPU0H2qFvm_jHKsYZ0yr_QY4HxK9X_3Z9A73zccA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3134864593</pqid></control><display><type>article</type><title>Cancer and Portfolio Choice: Evidence from Norwegian Register Data</title><source>OUP_牛津大学出版社现刊</source><source>EBSCOhost Business Source Complete</source><creator>Døskeland, Trond ; Kvaerner, Jens Soerlie</creator><creatorcontrib>Døskeland, Trond ; Kvaerner, Jens Soerlie</creatorcontrib><description>Abstract
We examine the personal investment decisions of 60,000 households following a cancer diagnosis. To create a control group that minimizes the likelihood that the results are confounded by lifestyle factors, we rely on households diagnosed with the same diagnosis but a few years later. Our estimates show that a cancer diagnosis reduces households’ willingness to take risks with their financial wealth. We use the vast heterogeneity among cancers regarding its impact on life expectancy (LE) and income to analyze through which channels cancer impact risk-taking. We find that cancers that have a greater impact on LE and income cause a larger reduction in risk-taking. These two channels account for about 40–90% of the estimated effects of cancer on personal investment decisions. We do not find any association between having dealt with cancer many years ago and current portfolio choices.</description><identifier>ISSN: 1572-3097</identifier><identifier>EISSN: 1573-692X</identifier><identifier>EISSN: 1875-824X</identifier><identifier>DOI: 10.1093/rof/rfab022</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><ispartof>Review of Finance, 2022-03, Vol.26 (2), p.407-442</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the European Finance Association. All rights reserved. For permissions, please email: journals.permissions@oup.com 2021</rights><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the European Finance Association. All rights reserved. For permissions, please email: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-3c6082617ef9d6c5288db8c53dd2c77894b0cca49a3a407c513cb924db3ce3c43</citedby><cites>FETCH-LOGICAL-c419t-3c6082617ef9d6c5288db8c53dd2c77894b0cca49a3a407c513cb924db3ce3c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids></links><search><creatorcontrib>Døskeland, Trond</creatorcontrib><creatorcontrib>Kvaerner, Jens Soerlie</creatorcontrib><title>Cancer and Portfolio Choice: Evidence from Norwegian Register Data</title><title>Review of Finance</title><description>Abstract
We examine the personal investment decisions of 60,000 households following a cancer diagnosis. To create a control group that minimizes the likelihood that the results are confounded by lifestyle factors, we rely on households diagnosed with the same diagnosis but a few years later. Our estimates show that a cancer diagnosis reduces households’ willingness to take risks with their financial wealth. We use the vast heterogeneity among cancers regarding its impact on life expectancy (LE) and income to analyze through which channels cancer impact risk-taking. We find that cancers that have a greater impact on LE and income cause a larger reduction in risk-taking. These two channels account for about 40–90% of the estimated effects of cancer on personal investment decisions. We do not find any association between having dealt with cancer many years ago and current portfolio choices.</description><issn>1572-3097</issn><issn>1573-692X</issn><issn>1875-824X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMouK6e_AMBwYvUTTJpm3jTun7AoiIK3kI6TbXLbrMmXcV_b7UL3jy9A_PMO_AQcsjZKWcaJsHXk1DbkgmxRUY8zSHJtHjZ_p1FAkznu2QvxjljAALSEbkobIsuUNtW9MGHrvaLxtPizTfozuj0o6lcv6d18Et658One21sSx_7iF1_dmk7u092aruI7mCTY_J8NX0qbpLZ_fVtcT5LUHLdJYAZUyLjuat1lWEqlKpKhSlUlcA8V1qWDNFKbcFKlmPKAUstZFUCOkAJY3I09K6Cf1-72Jm5X4e2f2mAg1SZTDX01MlAYfAxBlebVWiWNnwZzsyPJNNLMhtJPU0H2qFvm_jHKsYZ0yr_QY4HxK9X_3Z9A73zccA</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Døskeland, Trond</creator><creator>Kvaerner, Jens Soerlie</creator><general>Oxford University Press</general><scope>OQ6</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220301</creationdate><title>Cancer and Portfolio Choice: Evidence from Norwegian Register Data</title><author>Døskeland, Trond ; Kvaerner, Jens Soerlie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-3c6082617ef9d6c5288db8c53dd2c77894b0cca49a3a407c513cb924db3ce3c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Døskeland, Trond</creatorcontrib><creatorcontrib>Kvaerner, Jens Soerlie</creatorcontrib><collection>ECONIS</collection><collection>CrossRef</collection><jtitle>Review of Finance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Døskeland, Trond</au><au>Kvaerner, Jens Soerlie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer and Portfolio Choice: Evidence from Norwegian Register Data</atitle><jtitle>Review of Finance</jtitle><date>2022-03-01</date><risdate>2022</risdate><volume>26</volume><issue>2</issue><spage>407</spage><epage>442</epage><pages>407-442</pages><issn>1572-3097</issn><eissn>1573-692X</eissn><eissn>1875-824X</eissn><abstract>Abstract
We examine the personal investment decisions of 60,000 households following a cancer diagnosis. To create a control group that minimizes the likelihood that the results are confounded by lifestyle factors, we rely on households diagnosed with the same diagnosis but a few years later. Our estimates show that a cancer diagnosis reduces households’ willingness to take risks with their financial wealth. We use the vast heterogeneity among cancers regarding its impact on life expectancy (LE) and income to analyze through which channels cancer impact risk-taking. We find that cancers that have a greater impact on LE and income cause a larger reduction in risk-taking. These two channels account for about 40–90% of the estimated effects of cancer on personal investment decisions. We do not find any association between having dealt with cancer many years ago and current portfolio choices.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><doi>10.1093/rof/rfab022</doi><tpages>36</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1572-3097 |
| ispartof | Review of Finance, 2022-03, Vol.26 (2), p.407-442 |
| issn | 1572-3097 1573-692X 1875-824X |
| language | eng |
| recordid | cdi_proquest_journals_3134864593 |
| source | OUP_牛津大学出版社现刊; EBSCOhost Business Source Complete |
| title | Cancer and Portfolio Choice: Evidence from Norwegian Register Data |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A41%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20and%20Portfolio%20Choice:%20Evidence%20from%20Norwegian%20Register%20Data&rft.jtitle=Review%20of%20Finance&rft.au=D%C3%B8skeland,%20Trond&rft.date=2022-03-01&rft.volume=26&rft.issue=2&rft.spage=407&rft.epage=442&rft.pages=407-442&rft.issn=1572-3097&rft.eissn=1573-692X&rft_id=info:doi/10.1093/rof/rfab022&rft_dat=%3Cproquest_cross%3E3134864593%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3134864593&rft_id=info:pmid/&rft_oup_id=10.1093/rof/rfab022&rfr_iscdi=true |